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Polyvinylpyrrolidone (PVP) is a polymer derived from 
the monomer N-vinylpyrrolidone, an organic compound 
consisting of a 5-membered lactam linked to a vinyl group. It is 
widely used in medical products as an excipient, especially in 
tablet formulations, and in ophthalmic solutions as a lubricant. 
When linked to iodine, it is called povidone-iodine, which is 
used as an antiseptic agent.
Even though PVP has been considered safe to date, cases 
of adverse reactions have been reported. While skin reactions 
to PVP from cutaneous exposure, such as contact dermatitis, 
are frequent, only a few cases of anaphylaxis from various 
administration routes have been described in the literature [1-5].
Few cases of anaphylaxis to eye drops have been reported; 
some involved reactions to the active ingredient [6,7] and 
only 1 to the preservative, benzalkonium chloride [8].
We report the first case of anaphylaxis to PVP as an 
excipient in an ophthalmic preparation.
A 15-year-old girl was referred to the Allergy Unit of the 
Anna Meyer Children’s Hospital, Florence, Italy because of 
suspected anaphylaxis to eye drops.
The only relevant information in her clinical history was 
a previous reaction following exposure to a hairspray at the 
hairdresser’s some months earlier. At that time, the patient 
experienced cutaneous itching of the scalp, tearing, and cough. 
The symptoms cleared up spontaneously in a few minutes.
Two months before our evaluation, she had conjunctivitis 
and was treated with topical tobramycin and dexamethasone 
eye drops, with no reaction. A month and half later, owing 
to recurrent conjunctivitis, the ophthalmologist prescribed 
another type of corticosteroid eye drops, which contained 
loteprednol. Immediately after the administration of one drop 
in both eyes, she developed anaphylaxis (periorbital swelling, 
angioedema of the tongue and lips, dyspnea with a sensation of 
nasal obstruction, and throat constriction). At the emergency 
department, she was given epinephrine, antihistamines, and 
oral corticosteroids, and her symptoms resolved progressively. 
A blood analysis during the episode revealed total IgE of 
3850 kU/L (normal range, 0-100 kU/L).
Two weeks after being discharged, the patient was admitted 
to our Allergy Unit. Prick-by-prick testing with the culprit eye 
drops containing loteprednol 0.5% yielded a positive result 
after 10 minutes (Table). Histamine (ALK-Abelló; 10 mg/mL) 
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was used as a positive control. Skin prick tests with common 
inhalants (commercial extracts of pollens, mites, molds, cat 
and dog epithelia, and latex [0.1 mg/mL, ALK Abelló]) proved 
positive to mites.
In the search for a possible allergy to one of the excipients 
contained in the eye drop formulations, we checked the 
ingredients of both ophthalmological products (ie, the culprit 
product and the previously tolerated eye drops), which proved 
to be the same except for 1 excipient (ie, povidone). In order 
to exclude possible sensitization to most of the excipients 
contained in both eye drops, the tolerated product was also 
tested using the prick-by-prick approach, and the results 
were negative. The only remaining suspect excipient was 
povidone, which was present in the culprit eye drops, but not 
in the tobramycin and dexamethasone eye drops. We then 
performed prick-by-prick testing with povidone iodine 7.5% 
antiseptic solution, which is routinely used as a disinfectant 
in the hospital. The result  was positive (Table). Given that 
many drugs contain povidone and PVP as excipients, we 
searched for the most frequently used drugs containing one 
of these substances. The search revealed a paracetamol tablet 
formulation with PVP; therefore, we performed prick-by-prick 
testing with the powder of a crushed tablet, and the result was 
positive (Table). In the past, the patient had always used PVP-
free acetaminophen suppositories. Lastly, in order to exclude 
an iodine allergy (since adverse reactions to iodinated contrast 
media are not uncommon [9]), we also tested an intravenous 
iodinated contrast agent using prick-by-prick testing, which 
was negative.
In conclusion, we advised the patient and her parents to 
avoid preparations, cosmetic products, and food containing 
PVP. We prescribed self-injectable epinephrine for immediate 
management of anaphylaxis and trained the patient in how 
to use it.
PVP is widely used in many products. It can be found in 
personal care items such as hair styling products, as was the 
case of the previous cutaneous and respiratory reaction that 
the patient experienced on exposure to hairspray.
In pharmacology, PVP is used as a binder, especially in 
tablets, and as a lubricant in eye drops, as well as an antiseptic 
agent when linked with iodine. PVP is also used as a food 
additive, with E number E1201.
Although the possibility of povidone anaphylaxis 
is known in literature, this is the first pediatric case of 
anaphylaxis to PVP in eye drops. In the case we report, it 
was easy to show that the agent causing the adverse reaction 
was the excipient and not the active ingredient, thanks to 
the availability of the formulation of both the ophthalmic 
preparations. It was very important for the patient to discover 
that she was allergic to such a frequently used substance. In 
our opinion, if a single intraocular drop triggered a medium-
severity adverse reaction, then accidental oral ingestion of 
PVP in a drug or in food could have caused much more 
severe anaphylaxis.
Even though self-injectable epinephrine prescription is 
not recommended in the case of anaphylaxis to drugs [10], 
we provided the patient with this life-saving drug, as 
povidone/PVP/E1201 is so widespread and found in 
many brands of medications containing the same active 
ingredient. Moreover, we took into account the possible risk 
of recurrence or accidental contact (ie, at the hairdresser’s).
In summary, the case we report stresses the need for an 
accurate allergy work-up in order to reach a confident diagnosis 
and give advice to the patient on which drugs can or cannot be 
used in order to avoid life-threatening reactions.
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Angioedema involves rapid swelling of the skin, which 
typically lasts no more than 5-7 days. The affected tissues 
return to normal with no sequelae. Some entities with facial 
swelling can be misdiagnosed with angioedema. Such is the 
case of Melkersson-Rosenthal syndrome (MRS) [1]. 
MRS is a systemic disease characterized by idiopathic 
facial paralysis, fissured tongue, and orofacial edema that 
persists for weeks or months. The syndrome was described 
separately by Melkersson in 1928 and Rosenthal in 1931 [2]. 
The classic triad is rarely present, with oligosymptomatic 
or monosymptomatic forms being more frequent. 
We describe the case of a 67-year-old woman who was 
referred to our Allergy Department because of recurrent facial 
angioedema. 
She had a personal history of diabetes mellitus, 
dyslipidemia, hypertension, allergic rhinitis, and sensitization 
to Anisakis simplex.
At the age of 27 years, she experienced an episode of 
right facial paralysis, with complete recovery (no visible 
sequelae) approximately 10 days after treatment with 
corticosteroids.
In January 2011, she experienced a new episode of right 
facial paralysis with edema of the upper lip and without 
pruritus or erythema. She improved slightly with systemic 
corticosteroids. A month after this episode, she had a new 
episode of facial edema associated with another episode 
of facial paralysis with right ptosis, lagophthalmos, and 
dysgeusia. Slight facial asymmetry due to residual edema 
persisted (Figure).
During the following years, she had a further 6 episodes of 
facial edema, all of which lasted 5 to 7 days, with an incomplete 
response to antihistamines. She was sent to the Allergy Unit 
for recurrent angioedema. After the last episode, the slight 
facial swelling became progressively permanent. On physical 
examination, she presented a fissured tongue (Figure) and 
facial edema with no other symptoms.
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